These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 36116761)
41. Clinical and upper airway characteristics of 3715 patients with the Omicron variant of SARS-Cov-2 in Changchun, China. Sha J; Meng C; Sun J; Sun L; Gu R; Liu J; Zhu X; Zhu D J Infect Public Health; 2023 Mar; 16(3):422-429. PubMed ID: 36731245 [TBL] [Abstract][Full Text] [Related]
42. The clinical effectiveness of REGEN-COV in SARS-CoV-2 infection with Omicron versus Delta variants. Gershengorn HB; Patel S; Ferreira T; Das S; Parekh DJ; Shukla B PLoS One; 2022; 17(12):e0278770. PubMed ID: 36459537 [TBL] [Abstract][Full Text] [Related]
43. Severity of Illness in Persons Infected With the SARS-CoV-2 Delta Variant vs Beta Variant in Qatar. Butt AA; Dargham SR; Chemaitelly H; Al Khal A; Tang P; Hasan MR; Coyle PV; Thomas AG; Borham AM; Concepcion EG; Kaleeckal AH; Latif AN; Bertollini R; Abou-Samra AB; Abu-Raddad LJ JAMA Intern Med; 2022 Feb; 182(2):197-205. PubMed ID: 34935861 [TBL] [Abstract][Full Text] [Related]
44. Duration of viable virus shedding and polymerase chain reaction positivity of the SARS-CoV-2 Omicron variant in the upper respiratory tract: a systematic review and meta-analysis. Wu Y; Guo Z; Yuan J; Cao G; Wang Y; Gao P; Liu J; Liu M Int J Infect Dis; 2023 Apr; 129():228-235. PubMed ID: 36804640 [TBL] [Abstract][Full Text] [Related]
45. Estimates of SARS-CoV-2 Omicron BA.2 Subvariant Severity in New England. Strasser ZH; Greifer N; Hadavand A; Murphy SN; Estiri H JAMA Netw Open; 2022 Oct; 5(10):e2238354. PubMed ID: 36282501 [TBL] [Abstract][Full Text] [Related]
46. Factors Associated With Protection From SARS-CoV-2 Omicron Variant Infection and Disease Among Vaccinated Health Care Workers in Israel. Gilboa M; Gonen T; Barda N; Cohn S; Indenbaum V; Weiss-Ottolenghi Y; Amit S; Asraf K; Joseph G; Levin T; Kanaaneh Y; Aydenzon A; Canetti M; Freedman L; Zuckerman N; Mendelson E; Doolman R; Kreiss Y; Regev-Yochay G; Lustig Y JAMA Netw Open; 2023 May; 6(5):e2314757. PubMed ID: 37219906 [TBL] [Abstract][Full Text] [Related]
47. SARS-CoV-2 seroepidemiology in paediatric population during Delta and Omicron predominance. Filippatos F; Tatsi EB; Dellis C; Koukou DM; Papagiannopoulos C; Margeli A; Siahanidou T; Kanaka-Gantenbein C; Syriopoulou V; Michos A Epidemiol Infect; 2022 Oct; 150():e177. PubMed ID: 36345855 [TBL] [Abstract][Full Text] [Related]
48. Clinical and immunological features of convalescent pediatric patients infected with the SARS-CoV-2 Omicron variant in Tianjin, China. Wang JY; Li TN; Zhou CL; Zhao J; Wang M; Wang Y; Jiang Y; Dong HN; Qi QR; Mu H Virol Sin; 2022 Dec; 37(6):850-859. PubMed ID: 36328182 [TBL] [Abstract][Full Text] [Related]
49. Transmission of SARS-CoV-2 by children to contacts in schools and households: a prospective cohort and environmental sampling study in London. Cordery R; Reeves L; Zhou J; Rowan A; Watber P; Rosadas C; Crone M; Storch M; Freemont P; Mosscrop L; Cowley A; Zelent G; Bisset K; Le Blond H; Regmi S; Buckingham C; Junaideen R; Abdulla N; Eliahoo J; Mindlin M; Lamagni T; Barclay W; Taylor GP; Sriskandan S Lancet Microbe; 2022 Nov; 3(11):e814-e823. PubMed ID: 36029775 [TBL] [Abstract][Full Text] [Related]
50. Comparison of risk factors for SARS-CoV-2 infection among healthcare workers during Omicron and Delta dominance periods in Japan. Li Y; Yamamoto S; Oshiro Y; Inamura N; Nemoto T; Horii K; Takeuchi JS; Mizoue T; Konishi M; Ozeki M; Sugiyama H; Sugiura W; Ohmagari N J Hosp Infect; 2023 Apr; 134():97-107. PubMed ID: 36805085 [TBL] [Abstract][Full Text] [Related]
51. [Characteristics and related factors of viral nucleic acid negative conversion in children infected with Omicron variant strain of SARS-CoV-2]. Yin R; Lu Q; Jiao JL; Lin K; Wang C; Yuan L; Ding Y; Dong N; Wang BJ; Niu YH; Fang YS; Liu W; Sun YF; Zou B; Zhang XE; Xiao P; Sun L; Du X; Zhu YY; Dong XY Zhonghua Er Ke Za Zhi; 2022 Dec; 60(12):1307-1311. PubMed ID: 36444435 [No Abstract] [Full Text] [Related]
52. [Characteristics of SARS-CoV-2 Omicron infection in children imported from Hong Kong]. Ma WJ; Wang XS; Tian H; Zhu YF; Wei ZQ; Xu J; Zhu QR; Zeng M Zhonghua Er Ke Za Zhi; 2022 Jun; 60(6):539-544. PubMed ID: 35658359 [No Abstract] [Full Text] [Related]
53. Older age and depressive state are risk factors for re-positivity with SARS-CoV-2 Omicron variant. Li M; Peng H; Duan G; Wang J; Yu Z; Zhang Z; Wu L; Du M; Zhou S Front Public Health; 2022; 10():1014470. PubMed ID: 36268004 [TBL] [Abstract][Full Text] [Related]
54. Admissions to a large tertiary care hospital and Omicron BA.1 and BA.2 SARS-CoV-2 polymerase chain reaction positivity: primary, contributing, or incidental COVID-19. Voor In 't Holt AF; Haanappel CP; Rahamat-Langendoen J; Molenkamp R; van Nood E; van den Toorn LM; Peeters RP; van Rossum AMC; Severin JA Int J Infect Dis; 2022 Sep; 122():665-668. PubMed ID: 35842214 [TBL] [Abstract][Full Text] [Related]
55. Impact of SARS-CoV-2 Alpha and Gamma Variants among Symptomatic Pregnant Women: A Two-Center Retrospective Cohort Study between France and Brazil. Mosnino E; Bernardes LS; Mattern J; Hipólito Micheletti B; Aparecida de Castro Maldonado A; Vauloup-Fellous C; Doucet-Populaire F; De Luca D; Benachi A; Vivanti AJ J Clin Med; 2022 May; 11(9):. PubMed ID: 35566787 [TBL] [Abstract][Full Text] [Related]
56. Analyzing factors affecting positivity in drive-through COVID-19 testing: a cross-sectional study. Mori M; Yokoyama K; Sanuki R; Inoue F; Maekawa T; Moriyama T Virol J; 2024 May; 21(1):111. PubMed ID: 38745200 [TBL] [Abstract][Full Text] [Related]
57. Social Behaviors Associated with SARS-CoV-2 Test Positivity Among Children Evaluated in Canadian Emergency Departments, 2020 to 2022: A Cross-Sectional Survey Study. Sumner M; Tarr GAM; Xie J; Mater A; Winston K; Gravel J; Poonai N; Burstein B; Berthelot S; Zemek R; Porter R; Wright B; Kam A; Emsley J; Sabhaney V; Beer D; Freire G; Moffatt A; Freedman SB; Acad Pediatr; 2024 Aug; ():. PubMed ID: 39216802 [TBL] [Abstract][Full Text] [Related]
58. Acute and Postacute Clinical Characteristics of Coronavirus Disease 2019 in Children in Japan. Katsuta T; Aizawa Y; Shoji K; Shimizu N; Okada K; Nakano T; Kamiya H; Amo K; Ishiwada N; Iwata S; Oshiro M; Okabe N; Korematsu S; Suga S; Tsugawa T; Nishimura N; Hishiki H; Fujioka M; Hosoya M; Mizuno Y; Miyairi I; Miyazaki C; Morishima T; Yoshikawa T; Wada T; Ouchi K; Moriuchi H; Tanaka-Taya K; Saitoh A Pediatr Infect Dis J; 2023 Mar; 42(3):240-246. PubMed ID: 36730047 [TBL] [Abstract][Full Text] [Related]
59. Use of Rapid Antigen Triple Test Nasal Swabs (COVID-VIRO ALL-IN TRIPLEX: Severe Acute Respiratory Syndrome Coronavirus 2, Respiratory Syncytial Virus, and Influenza) in Children With Respiratory Symptoms: A Real-life Prospective Study. Cohen R; Haas H; Romain O; Béchet S; Romain C; de Lays CT; Wollner A; Guiheneuf C; de Pontual L; Levy C Open Forum Infect Dis; 2024 Jan; 11(1):ofad617. PubMed ID: 38173847 [TBL] [Abstract][Full Text] [Related]
60. From the original SARS-CoV-2 strain to the Omicron variant: Predictors of COVID-19 in ambulatory symptomatic children. Cohen R; Rybak A; Ouldali N; Angoulvant F; Béchet S; Gajdos V; Hau I; Sellam A; El Aouane El Ghomari I; Elmerich F; Batard C; Auvrignon A; Grimprel E; Favier M; Jung C; Levy C Infect Dis Now; 2022 Nov; 52(8):432-440. PubMed ID: 36116761 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]